ER
Elizabeth E Reed (SVP, GC & CORPORATE SECRETARY) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Travere Therapeutics, Inc. (TVTX). The largest single filing was $2.2M of TVTX (35,800 sh across 2 lots, as filed), executed Sep 15. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
8
0 buys · 8 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$6.7M
shares × price, as filed
Last traded
Sep 15
Filed Sep 17
Median ADV $123.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $7.4M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
8 filings
Sector per market data · by filing · past 12 months
Most traded names
TVTXRecent filings
TVTXSALE
Travere Therapeutics, Inc.
View filing →
$2.2M35,800 sh across 2 lots
Exec Sep 15
Filed Sep 17 · 9:32 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $1.0M
22,174 sh across 2 lots
Exec May 4
Filed May 6 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $2.1M
49,941 sh across 3 lots
Exec Apr 14
Filed Apr 15 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $300K
10,000 sh × $30.00
Exec Apr 1
Filed Apr 2 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $281K
10,000 sh × $28.09
Exec Mar 16
Filed Mar 18 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $278K
10,000 sh across 2 lots
Exec Feb 17
Filed Feb 19 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $230K
7,175 sh × $32.12
Exec Feb 3
Filed Feb 3 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $273K
10,000 sh × $27.34
Exec Jan 20
Filed Jan 21 · 5:30 PM ET More filings →